389 related articles for article (PubMed ID: 24590290)
21. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells.
Masui S; Nakatake Y; Toyooka Y; Shimosato D; Yagi R; Takahashi K; Okochi H; Okuda A; Matoba R; Sharov AA; Ko MS; Niwa H
Nat Cell Biol; 2007 Jun; 9(6):625-35. PubMed ID: 17515932
[TBL] [Abstract][Full Text] [Related]
22. Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma.
Shahryari A; Rafiee MR; Fouani Y; Oliae NA; Samaei NM; Shafiee M; Semnani S; Vasei M; Mowla SJ
Stem Cells; 2014 Jan; 32(1):126-34. PubMed ID: 24105929
[TBL] [Abstract][Full Text] [Related]
23. Selective influence of Sox2 on POU transcription factor binding in embryonic and neural stem cells.
Mistri TK; Devasia AG; Chu LT; Ng WP; Halbritter F; Colby D; Martynoga B; Tomlinson SR; Chambers I; Robson P; Wohland T
EMBO Rep; 2015 Sep; 16(9):1177-91. PubMed ID: 26265007
[TBL] [Abstract][Full Text] [Related]
24. Sex determining region Y-box 2 (SOX2) amplification is an independent indicator of disease recurrence in sinonasal cancer.
Schröck A; Göke F; Wagner P; Bode M; Franzen A; Braun M; Huss S; Agaimy A; Ihrler S; Menon R; Kirsten R; Kristiansen G; Bootz F; Lengerke C; Perner S
PLoS One; 2013; 8(3):e59201. PubMed ID: 23544055
[TBL] [Abstract][Full Text] [Related]
25. SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma.
Gen Y; Yasui K; Zen Y; Zen K; Dohi O; Endo M; Tsuji K; Wakabayashi N; Itoh Y; Naito Y; Taniwaki M; Nakanuma Y; Okanoue T; Yoshikawa T
Cancer Genet Cytogenet; 2010 Oct; 202(2):82-93. PubMed ID: 20875870
[TBL] [Abstract][Full Text] [Related]
26. Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing Sox2.
Brcic L; Sherer CK; Shuai Y; Hornick JL; Chirieac LR; Dacic S
Am J Clin Pathol; 2012 Nov; 138(5):712-8. PubMed ID: 23086772
[TBL] [Abstract][Full Text] [Related]
27. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
[TBL] [Abstract][Full Text] [Related]
28. Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells.
Liu X; Huang J; Chen T; Wang Y; Xin S; Li J; Pei G; Kang J
Cell Res; 2008 Dec; 18(12):1177-89. PubMed ID: 19030024
[TBL] [Abstract][Full Text] [Related]
29. SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma.
Fukazawa T; Guo M; Ishida N; Yamatsuji T; Takaoka M; Yokota E; Haisa M; Miyake N; Ikeda T; Okui T; Takigawa N; Maeda Y; Naomoto Y
Sci Rep; 2016 Feb; 6():20113. PubMed ID: 26846300
[TBL] [Abstract][Full Text] [Related]
30. A predominant enhancer co-amplified with the SOX2 oncogene is necessary and sufficient for its expression in squamous cancer.
Liu Y; Wu Z; Zhou J; Ramadurai DKA; Mortenson KL; Aguilera-Jimenez E; Yan Y; Yang X; Taylor AM; Varley KE; Gertz J; Choi PS; Cherniack AD; Chen X; Bass AJ; Bailey SD; Zhang X
Nat Commun; 2021 Dec; 12(1):7139. PubMed ID: 34880227
[TBL] [Abstract][Full Text] [Related]
31. Association of OCT4, SOX2, and NANOG expression with oral squamous cell carcinoma progression.
Fu TY; Hsieh IC; Cheng JT; Tsai MH; Hou YY; Lee JH; Liou HH; Huang SF; Chen HC; Yen LM; Tseng HH; Ger LP
J Oral Pathol Med; 2016 Feb; 45(2):89-95. PubMed ID: 26211876
[TBL] [Abstract][Full Text] [Related]
32. CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification.
Hur JY; Kim HR; Lee JY; Park S; Hwang JA; Kim WS; Yoon S; Choi CM; Rho JK; Lee JC
Cell Oncol (Dordr); 2019 Aug; 42(4):449-458. PubMed ID: 30838525
[TBL] [Abstract][Full Text] [Related]
33. The transcriptional foundation of pluripotency.
Chambers I; Tomlinson SR
Development; 2009 Jul; 136(14):2311-22. PubMed ID: 19542351
[TBL] [Abstract][Full Text] [Related]
34. Chromosome 3q26 Gain Is an Early Event Driving Coordinated Overexpression of the PRKCI, SOX2, and ECT2 Oncogenes in Lung Squamous Cell Carcinoma.
Liu Y; Yin N; Wang X; Khoor A; Sambandam V; Ghosh AB; Fields ZA; Murray NR; Justilien V; Fields AP
Cell Rep; 2020 Jan; 30(3):771-782.e6. PubMed ID: 31968252
[TBL] [Abstract][Full Text] [Related]
35. Combinatorial binding in human and mouse embryonic stem cells identifies conserved enhancers active in early embryonic development.
Göke J; Jung M; Behrens S; Chavez L; O'Keeffe S; Timmermann B; Lehrach H; Adjaye J; Vingron M
PLoS Comput Biol; 2011 Dec; 7(12):e1002304. PubMed ID: 22215994
[TBL] [Abstract][Full Text] [Related]
36. An integrated analysis of the SOX2 microRNA response program in human pluripotent and nullipotent stem cell lines.
Vencken SF; Sethupathy P; Blackshields G; Spillane C; Elbaruni S; Sheils O; Gallagher MF; O'Leary JJ
BMC Genomics; 2014 Aug; 15():711. PubMed ID: 25156079
[TBL] [Abstract][Full Text] [Related]
37. Enhancer identification in mouse embryonic stem cells using integrative modeling of chromatin and genomic features.
Chen CY; Morris Q; Mitchell JA
BMC Genomics; 2012 Apr; 13():152. PubMed ID: 22537144
[TBL] [Abstract][Full Text] [Related]
38. Gene dynamics of core transcription factors for pluripotency in embryonic stem cells.
David BG; Okamoto K; Kakizuka T; Ichimura T; Watanabe TM; Fujita H
J Biosci Bioeng; 2015 Apr; 119(4):406-9. PubMed ID: 25441442
[TBL] [Abstract][Full Text] [Related]
39. A positive regulatory role for the mSin3A-HDAC complex in pluripotency through Nanog and Sox2.
Baltus GA; Kowalski MP; Tutter AV; Kadam S
J Biol Chem; 2009 Mar; 284(11):6998-7006. PubMed ID: 19139101
[TBL] [Abstract][Full Text] [Related]
40. SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer.
Wilbertz T; Wagner P; Petersen K; Stiedl AC; Scheble VJ; Maier S; Reischl M; Mikut R; Altorki NK; Moch H; Fend F; Staebler A; Bass AJ; Meyerson M; Rubin MA; Soltermann A; Lengerke C; Perner S
Mod Pathol; 2011 Jul; 24(7):944-53. PubMed ID: 21460799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
